GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Formycon FYB.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

13.84

-1.14%

Close of 20 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Formycon — daily XETR:FYB End of day
Market value
€242.1m
Last close × shares
Volume
14.7k
Shares, 20 Nov 2026

About Formycon

Its shares trade on XETRA under the ticker FYB.DE. It has been listed since 20 December 2010. In the fiscal year to 31 December 2025, it reported revenue of €44.5m and a net loss of €64.7m. At that date it held total assets of €739.5m and shareholders' equity of €399.1m.

Formycon AG engages in the manufacture of biosimilar drugs and formulations. The company is headquartered in Martinsried, Bayern. The company went IPO on 2010-12-20. Its business activities are focused on the development and marketing of biopharmaceuticals that are similar to existing drugs, for which the patent protection is expiring. The firm focuses on treatments in the area of ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval. Its biosimilar product pipeline consists of four candidates in pre-clinical and clinical testing phases, including FYB201, a biosimilar candidate for Lucentis; FYB202, a biosimilar candidate for Stelara; FYB203, a biosimilar candidate for Eylea, and FYB205.

Figures and description from our data supplier, not checked against the company's own report.

More about Formycon →

Latest on Formycon

Our reporting

We have not reported on Formycon yet.

Next results

29 Apr 2027

Due on 29 Apr 2027. Analysts expect earnings of 0.06 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Formycon's ticker?

Formycon trades as FYB.DE on XETRA, under ISIN DE000A1EWVY8.

What was Formycon's last closing price?

13.84 on 20 Nov 2026. The figure is in EUR and is never converted.

When does Formycon next report results?

Results are expected on 29 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.